Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.400
-0.015 (-1.06%)
At close: Dec 19, 2025, 4:00 PM EST
1.430
+0.030 (2.14%)
After-hours: Dec 19, 2025, 5:29 PM EST
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $95.88 million as of December 19, 2025. Its market cap has increased by 174.73% in one year.
Market Cap
95.88M
Enterprise Value
162.08M
1-Year Change
174.73%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $95.88M, a decrease of -79.37%. That is a compound annual growth rate of -19.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 96.91M | 8.16% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |